Global impact

At GOAL 3, we believe that it is time for change! Read more about the impact of our work

Health worker showing colleagues the IMPALA Monitor touchscreen during training
Health worker reviewing patient data on a computer and the IMPALA tablet

Our Evidence

Complete Evidence Overview

Fill out your email and get direct access to the document!

If you have questions about our GOAL, want to learn more, have a tip, or are interested in working/partnering with us, please use the form to contact us. We'll get back to you ASAP.
Thank you! 🙏
Visit Site
Oops! Something went wrong while submitting the form.
Close
Health workers and the GOAL 3 team talking at an infant's bedside on a ward

IMPALA is Cost-Effective

Rethink Priorities' independent review estimates IMPALA at US$7–17 per DALY averted on paediatric wards and US$12–30 in neonatal units, against an average willingness-to-pay of US$250–600 in low- and middle-income countries. These estimates already discount the observed mortality effects by 60% for internal validity and a further 30% for external validity.

In the Malawi cost-effectiveness study, IMPALA cost about US$2.90 per admitted child. On paediatric wards, health-system costs fell by US$1.90–13.10 and societal costs by US$11.60–45.10 per child (BMJ Paediatrics Open).

Complete Evidence Overview

Fill out your email and get direct access to the document!

If you have questions about our GOAL, want to learn more, have a tip, or are interested in working/partnering with us, please use the form to contact us. We'll get back to you ASAP.
Thank you! 🙏
Visit Site
Oops! Something went wrong while submitting the form.
Close
Newborn on a neonatal ward bed with IMPALA Monitors mounted above

IMPALA Transforms Patient Outcomes


Before-and-after studies at two Malawian hospitals found 40% and 51% lower paediatric mortality, and critical illness events fell by 25.5 and 47.1 percentage points.

Emerging data: neonatal mortality 20–35% lower in four of five hospitals; two of the five results are statistically significant.

Two health workers reviewing patients on the IMPALA tablet at a nurses' station

IMPALA empowers health workers

Health workers report 45% less time on monitoring (3.3 to 1.8 hours a day, self-reported). 92% of 116 health workers in four Rwandan hospitals report a lower workload (unpublished data). 98.8% of trained users in a real-world study would (very) likely recommend IMPALA.

Fill out your email and get direct access to the document!

If you have questions about our GOAL, want to learn more, have a tip, or are interested in working/partnering with us, please use the form to contact us. We'll get back to you ASAP.
Thank you! 🙏
Download now
Oops! Something went wrong while submitting the form.
Close

It is time for change!

The right to health is universal. Every person should have access to healthcare. Therefore, it is unacceptable that billions of people do not have access to adequate healthcare and every year millions die from treatable conditions. Fighting this injustice is what motivates us and what keeps us up at night. If we want to address this need successfully, we need to work smart and we need to work together. And we know we are not alone. All over the world there are health workers fighting for their patients, even in the most challenging settings. These people are essential in getting patients the care they need and deserve.

Inquire Today!

If you have questions about our GOAL, want to learn more, have a tip, or are interested in working/partnering with us, please use the form to contact us. We'll get back to you ASAP.
Thank you! We have received your message. All relevant submissions will be responded to within a week.
Oops! Something went wrong while submitting the form. Please try again.